Cargando…

Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) accounts for approximately 30% of non-Hodgkin lymphoma (NHL) cases in adult series. DLBCL is characterized by marked clinical and biological heterogeneity, encompassing up to 16 distinct clinicopathological entities. While current treatments are effective in 60%...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Barca, Eva, Coronado, Mónica, Martín, Alejandro, Montalbán, Carlos, Montes-Moreno, Santiago, Panizo, Carlos, Rodríguez, Guillermo, Sancho, Juan Manuel, López-Hernández, Andrés
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122355/ https://www.ncbi.nlm.nih.gov/pubmed/30190794 http://dx.doi.org/10.18632/oncotarget.25892

Ejemplares similares

Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study
por: García-Sancho, Alejandro Martín, et al.
Publicado: (2022)

R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group
por: Sancho, Juan‐Manuel, et al.
Publicado: (2021)

Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups
por: Bastos-Oreiro, Mariana, et al.
Publicado: (2022)

Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups
por: Rey-Búa, Beatriz, et al.
Publicado: (2022)

Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma
por: Hong, Junshik, et al.
Publicado: (2017)

PB2329: ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA (EATL): MULTICENTRIC REVIEW OF CLINICAL FEATURES AND TREATMENT: ON BEHALF OF GELTAMO (GRUPO ESPAÑOL DE LINFOMAS Y TRASPLANTES DE MÉDULA ÓSEA)
por: Infante, Maria Stefania, et al.
Publicado: (2023)

Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience
por: Gutierrez, Antonio, et al.
Publicado: (2022)

P1128: CLINICAL FEATURES AND OUTCOME OF PATIENTS WITH CASTLEMAN DISEASE: A SPANISH MULTICENTRIC STUDY OF 134 PATIENTS FROM GELTAMO
por: Navarro, J. T., et al.
Publicado: (2022)

Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker
por: Batlle-López, Ana, et al.
Publicado: (2016)

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma
por: González-Rincón, Julia, et al.
Publicado: (2019)

Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era
por: Gutierrez, Antonio, et al.
Publicado: (2020)

Role of Bispecific Antibodies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the CART Era
por: González Barca, Eva
Publicado: (2022)

P1083: BRENTUXIMAB VEDOTIN, ETOPOSIDE, SOLUMEDROL, HIGH DOSE ARA-C & PLATINUM FOLLOWED BY HDT & APBSCT FOR REFRACTORY/RELAPSED HODGKIN LYMPHOMA PATIENTS: LONG-TERM RESULTS OF THE GELTAMO GROUP BRESHAP STUDY
por: Garcia-Sanz, R., et al.
Publicado: (2022)

IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice
por: Sancho, Juan-Manuel, et al.
Publicado: (2022)

Low-Dose PET/CT and Full-Dose Contrast-Enhanced CT at the Initial Staging of Localized Diffuse Large B-Cell Lymphomas
por: Sabaté-Llobera, Aida, et al.
Publicado: (2016)

Lymphoplasmacytic lymphoma associated with diffuse large B-cell lymphoma: Progression or divergent evolution?
por: Boiza-Sánchez, Macarena, et al.
Publicado: (2020)

Diffuse Large B-Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up
por: Al-Mansour, Mubarak, et al.
Publicado: (2019)

Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma
por: Gonzalez-Farre, Blanca, et al.
Publicado: (2019)

An integrated prognostic model for diffuse large B‐cell lymphoma treated with immunochemotherapy
por: Rodríguez, Marta, et al.
Publicado: (2022)

Clinical and pathological characteristics of peripheral T‐cell lymphomas in a Spanish population: a retrospective study
por: Rodriguez‐Pinilla, Socorro Maria, et al.
Publicado: (2020)

SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022)
por: Gumà, Josep, et al.
Publicado: (2023)

Safety of switching from intravenous to subcutaneous rituximab during first‐line treatment of patients with non‐Hodgkin lymphoma: the Spanish population of the MabRella study
por: García‐Muñoz, Ricardo, et al.
Publicado: (2019)

Composite lymphoma associating diffuse large B‐cell lymphoma with classical Hodgkin lymphoma
por: Lauwers, Maïlis, et al.
Publicado: (2022)

The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good
por: Menéndez, Victoria, et al.
Publicado: (2022)

Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment
por: Montes-Moreno, S.
Publicado: (2011)

Integration of molecular testing for the personalized management of patients with diffuse large B-cell lymphoma and follicular lymphoma
por: Stuckey, Ruth, et al.
Publicado: (2023)

Simultaneous Presence of Follicular Lymphoma, Diffuse Large B-cell Lymphoma, and Hodgkin-like Lymphoma
por: Papoudou-Bai, Alexandra, et al.
Publicado: (2018)

Composite Lymphoma Comprising Extranodal NK/T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma
por: Nagai, Shin, et al.
Publicado: (2018)

Vitreoretinal lymphoma followed by systemic diffuse large B cell lymphoma
por: Fan, Kenneth C., et al.
Publicado: (2019)

A Case of Diffuse Large B-Cell Lymphoma Mimicking Primary Effusion Lymphoma-Like Lymphoma
por: Usuda, Daisuke, et al.
Publicado: (2017)

Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
por: Bartlett, Nancy L., et al.
Publicado: (2023)

Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets
por: Mata, Elena, et al.
Publicado: (2017)

Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry
por: Provencio, Mariano, et al.
Publicado: (2017)

Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma
por: Bellitti, Emilio, et al.
Publicado: (2022)

A composite lymphoma combining a Hodgkin lymphoma and a marginal zone lymphoma transformed into a diffuse large B‐cell lymphoma
por: Auditeau, Claire, et al.
Publicado: (2018)

Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma
por: Melchor, Javier, et al.
Publicado: (2023)

Primary bone lymphoma of the mandible and thyroid incidentaloma identified by (18)FDG PET/CT: a case report
por: Bosch-Barrera, Joaquim, et al.
Publicado: (2009)

Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care
por: Brotons, Carlos, et al.
Publicado: (2013)

A Case of Composite Lymphoma with Extranodal NK/T-cell Lymphoma, Nasal-type and Diffuse Large B-cell Lymphoma
por: Kawai, Hidetsugu, et al.
Publicado: (2019)

Fibrin-associated diffuse large B-cell lymphoma with plasmacytic differentiation: case report and literature review
por: Moreno, Esther Moreno, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9s3hsguvdpkq23u31888m5s6g6